: 545 mục trong 28 trang
Thuốc Gốc
recombinant human mannan binding protein, recombinant human mannose binding lectin, rhmbp
Investigated for use/treatment in immunodeficiency and infectious and parasitic disease (unspecified).
Thuốc Gốc
flamazine, silvadene, silver sulfadiazinate
Indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns.
Thuốc Gốc
samarium sm 153 lexidronam
Investigated for use/treatment in bone metastases, multiple myeloma, prostate cancer, and rheumatoid arthritis.
Thuốc Gốc
Investigated for use/treatment in male hormonal deficiencies/abnormalities and sexual dysfunction (female).
Thuốc Gốc
4 bromo 2 fluoro n 4e 6 methoxy 7 1 methylpiperidin 4 yl methoxy quinazolin 4 1h ylidene aniline, 4 quinazolinamine n 4 bromo 2 fluorophenyl 6 methoxy 7 1 methyl 4 piperidinyl methoxy, n 4 bromo 2 fluorophenyl 6 methoxy 7 1 methyl 4 piperidinyl methoxy 4 quinazolinamine
Vandetanib is currently approved as an alternative to local therapies for both unresectable and disseminated disease. Because Vandetanib can prolong the Q-T interval, it is ...
Thuốc Gốc
vb4 845
Investigated for use/treatment in bladder cancer and head and neck cancer.
Thuốc Gốc
Thuốc Gốc
Thuốc Gốc
Investigated for use/treatment in inflammatory disorders (unspecified) and pain (acute or chronic).
Thuốc Gốc
Thuốc Gốc
Thuốc Gốc
Investigated for use/treatment in adverse effects (chemotherapy) and bone marrow transplant.
Thuốc Gốc
Investigated for use/treatment in neuropathy (diabetic) and peripheral vascular disease.
Thuốc Gốc
Investigated for use/treatment in bladder cancer, lymphoma (unspecified), multiple myeloma, paget's disease, and prostate cancer.
Thuốc Gốc
otelixizumab
Investigated for use/treatment in diabetes mellitus type 1, pediatric indications, and psoriasis and psoriatic disorders.
Thuốc Gốc
cnto 1275, ustekinumab
Investigated for use/treatment in psoriasis and psoriatic disorders.
Thuốc Gốc
Thuốc Gốc
Thuốc Gốc
Thuốc Gốc
trastuzumab emtansine, trastuzumab dm1, trastuzumab mcc dm1
Used in HER2-positive, metastatic breast cancer patients who have already used taxane and/or trastuzumab for metastatic disease or had their cancer recur within 6 months of ...